Collegium Pharma (COLL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 148,713 | 134,910 | 146,633 | 139,790 | 133,747 |
| Receivables | 81,279 | 85,139 | 77,946 | 66,533 | 68,380 |
| Inventories | 9,953 | 8,741 | 7,817 | 9,229 | 8,544 |
| TOTAL | $244,563 | $233,843 | $237,512 | $218,977 | $216,293 |
| Non-Current Assets | |||||
| PPE Net | 10,367 | 9,962 | 9,274 | 6,039 | 3,203 |
| Intangibles | 36,879 | 40,567 | 44,255 | 421,287 | 453,694 |
| Other Non-Current Assets | 9,772 | 9,990 | 204 | 205 | 139 |
| TOTAL | $57,018 | $60,519 | $53,733 | $427,531 | $457,036 |
| Total Assets | $301,581 | $294,362 | $291,245 | $646,508 | $673,329 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,917 | 2,464 | 1,642 | 117,155 | 114,825 |
| Accounts payable and accrued liabilities | 10,941 | 13,733 | 12,150 | 11,679 | 18,692 |
| Accrued Expenses | 182,781 | 172,165 | 175,334 | 151,387 | 131,185 |
| TOTAL | $196,272 | $188,885 | $189,126 | $280,221 | $264,702 |
| Non-Current Liabilities | |||||
| Long Term Debt | 9,583 | 9,036 | 9,858 | 295,507 | 325,946 |
| Other Non-Current Liabilities | 9,903 | 10,091 | 676 | 0 | 0 |
| TOTAL | $19,486 | $19,127 | $10,534 | $295,507 | $325,946 |
| Total Liabilities | $215,758 | $208,012 | $199,660 | $575,728 | $590,648 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 33,471 | 33,387 | 33,305 | 33,247 | 33,222 |
| Common Shares | 33 | 33 | 33 | 33 | 33 |
| Retained earnings | -351,589 | -346,877 | -337,177 | -346,263 | -329,761 |
| TOTAL | $85,823 | $86,350 | $91,585 | $70,780 | $82,681 |
| Total Liabilities And Equity | $301,581 | $294,362 | $291,245 | $646,508 | $673,329 |